2020-12-09 06:17:14+00:00
 Gold prices eased on Wednesday as encouraging vaccine developments pushed investors towards riskier equities, although hopes for more U.S. stimulus kept bullion near two-week highs hit in the previous session.
Spot gold fell 0.3% to $1,865.46 per ounce by 0309 GMT, after hitting its highest since Nov. 23 at $1875.07 on Tuesday, while U.S. gold futures eased 0.3% to $1,870.20.
Gold is seen as a hedge against inflation that might result from the unprecedented stimulus pumped into the economy this year.
Buoying Asian shares to record highs, Johnson & Johnson said it could obtain late-stage trial results of a single-dose Covid-19 vaccine it is developing earlier than expected.
Silver slipped 0.7% to $24.38 an ounce, while platinum rose 0.6% to $1,028.17 and palladium was up 0.1% to $2,311.87.